Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 08 10 2018
revised: 15 11 2018
accepted: 16 11 2018
pubmed: 16 12 2018
medline: 27 6 2019
entrez: 16 12 2018
Statut: ppublish

Résumé

Pulmonary surfactant (PS) is a lipid-protein complex essential to stabilise the delicate structure of mammalian alveoli along with successive compression-expansion respiratory cycles. To do so, surfactant reduces dramatically surface tension at the air-liquid interface, an activity that depends critically on a proper lipid composition and the presence of some specific surfactant proteins. Lack or dysfunction of this system is associated with severe respiratory pathologies, which are in some cases treated by supplementation with exogenous surfactant materials. The biophysical function and performance of PS, in health and disease, are directly influenced by its composition, structure and mechanical properties. This review summarises the main biophysics concepts behind the mechanisms that define surfactant function in a healthy lung and in pathological situations. It also revises some of the most useful biophysical techniques that provide information about surfactant-related processes. Finally, translational biophysics will be invoked to illustrate how biophysical studies may contribute to understand the role of surfactant in health and disease and to design better surfactant-based therapeutic approaches.

Identifiants

pubmed: 30552091
pii: archdischild-2018-315413
doi: 10.1136/archdischild-2018-315413
doi:

Substances chimiques

Membrane Lipids 0
Phospholipids 0
Pulmonary Surfactants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

F443-F451

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Chiara Autilio (C)

Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, Madrid, Spain.
Research Institute "Hospital 12 de Octubre", Complutense University, Madrid, Spain.

Jesús Pérez-Gil (J)

Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, Madrid, Spain.
Research Institute "Hospital 12 de Octubre", Complutense University, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH